Blood when you throw up, or vomit that looks like coffee grounds. Start studying anticoagulant, antiplatelet, and thrombolytic drugs ppt learn vocabulary, terms, and more with flashcards, games, and other study tools. Dos and donts of antiplatelet use for secondary stroke. Antiplatelet agents are widely used for the secondary prophylaxis of.
If the patient is not a candidate for fibrinolytic therapy. Antiplatelet treatment in ischemic stroke treatment. Antiplatelet agents in secondary stroke prevention. Check the patients blood glucose and treat if indicated. The clopidogrel in highrisk patients with acute nondisabling cerebrovascular events chance trial tested the effect of early dual antiplatelet treatment for the prevention of secondary stroke within the first 90 days following a qualifying transient ischemic attack tia or minor stroke in 5170 chinese patients. Ppt antiplatelet therapy for the prevention of stroke in af powerpoint presentation free to download id. Current management of spontaneous intracerebral haemorrhage. Aspirin remains the only antiplatelet agent for which data support use in acute stroke, although trials with other agents are in progress. Our findings support the hypothesis that antiplatelet therapy modifies the potential benefits of lowering homocysteine with bvitamin supplementation in the secondary prevention of major vascular events. Specifically, does dual antiplatelet therapy with a combination of aspirin and clopidogrel lead to a greater reduction in recurrent stroke and death over the use of aspirin alone when given in the first 24 hours after a high risk transient ischaemic attack or minor. Ppt antiplatelet and anticoagulant therapy in stroke. Antithrombotic therapy is a cornerstone of primary and secondary prevention of ischaemic coronary artery disease and stroke. In patients with left ventricular assist device support and aspirin allergy, the choice of effective antiplatelet strategy remains a challenge. Dual antiplatelet therapy with aspirin clopidogrel and clopidogrel in monotherapy had similar longterm risk of recurrent stroke or 0.
Those randomized to dual antiplatelet therapy received 300 mg of clopidogrel on day 1 and 75 mg on days 2 through 90, with aspirin placebo on days 22 through 90. Number needed to treat to benefit compared to clopidogrel is high, especially after the first 30 days. Antiplatelet therapy for the secondary prevention of. Dipyridamole coronary vasodilator and relatively weak antiplatelet drug mechanism of action potentiates effect of endogenous prostacycline in high conc inhibits phosphodiesterase, so camp dose 100 mg bdtds used with aspirin to prevent ischemic stroke in patients of tia 16. Call your healthcare provider right away or go to the closest emergency room if you have. Combination antiplatelet therapy for transient ischemic. Give thiamine if the patient is an alcoholic or malnourished. How effective is dual antiplatelet therapy for secondary prevention of. Much less expensive and less dangerous than iv antiplatelet meds. Plateletaggregation inhibition is not significant until after approximately 4 days of regular dosing. Newer antiplatelet drugs authorstream presentation. The relationships among dose, efficacy, and safety are discussed along with a mechanistic overview of results of randomized clinical trials. Antiplatelet therapy reduces the incidence of stroke in patients at high risk for atherosclerosis and in those with known symptomatic cerebrovascular disease.
What is the role of dual antiplatelet therapy after high risk transient ischaemic attack or minor stroke. Accaha versus esc guidelines on dual antiplatelet therapy. The proportion of patients with ischemic stroke assigned to the different antiplatelet regimens during the study period is shown in fig. It can be either a transient episode called as transient ischemic attack tia, or it could last longer than 24 hours giving rise to infarction of tissues in the central nervous system. Prescribers of dapt are confronted with a number of challenges that include selecting the appropriate p2y12 inhibitor and determining the optimal. The europeanaustralasian stroke prevention in reversible ischemia trial esprit showed that the combination of aspirin and dipyridamole was preferable to.
This retrospective study identified very elderly 85 years patients, who were medically managed, with their first ami from the taiwan national health insurance claims database from 2007 to. Stia007 the percentage of patients with a stroke shown to be nonhaemorrhagic, or a history of tia, who have a record in the preceding 12. Acs and when strong antiplatelet action required prodrug but faster and complete absorption completely. We compared the antithrombotic effect of clopidogrel vs ticagrelor in an lvad patient with aspirin allergy by using a modified protocol of the thrombin generation test, accounting selectively for the platelet contribution on thrombin generation. Time trends in antiplatelet regimens after ischemic stroke. The high prevalence and burden of ischemic stroke and transient ischemic attack tia represent a significant clinical challenge. Now, again, extrapolating data from the antiplatelet trialists collaboration, you can see here that in patients allocated to antiplatelet therapy vs control, the reduction of a stroke, fatal and not fatal, will be by about 20%, so a patient who suffers a cerebrovascular event, tia, or stroke of noncardioembolic origin it will have a benefit of. Antiplatelet therapy after ischemic stroke or tia nejm. Platelet function returns to normal within 12 weeks as new platelets replace those affected by ticlopidine or clopidogrel. Approximately 20% of patients who have had a transient ischemic attack tia or minor stroke will have a recurrent vascular event within 1 year. Dual antiplatelet therapy dapt is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications in patients with a variety of coronary artery disease cad manifestations.
Primary death or dependence greater than 30 days after stroke. Ischemic stroke is defined as a sudden loss of blood to the brain which results in deprivation of oxygen and other nutrients. If you take plato platelet inhibition and patient outcomes for example, patients with prior stroke had a twofold increase in overall event rates of cardiovascular death, mi, and stroke, and they had a similar reduction in those events when they were treated with more potent antiplatelet therapy, ticagrelor compared with clopidogrel, so i. Despite aggressive public health initiatives aimed at curtailing common risk factors like hypertension, diabetes, and hyperlipidemia, stroke remains the fifthleading cause of death in the united states. Great advantages for loading doses in the cath lab or hospital. To examine the comparative effectiveness between dual and single antiplatelet therapies in realworld, medically managed elderly patients with acute myocardial infarction ami. The adobe flash plugin is needed to view this content. Dual antiplatelet therapy for highrisk tia and minor. Antiplatelet therapy for stroke prevention slides with transcript. From 2007 to 2010, the fraction of patients that received acetylsalicylic acid and the combination of acetylsalicylic acid and dipyridamole decreased from 19 to 12 %.
All patients received aspirin 75300 mg on day 1 and 75 mg of aspirin through day 21. Two large randomized trials tested the effects of aspirin in the acute phase of ischemic stroke. Patients who experience an ischemic stroke or transient ischemic attack tia while taking aspirin monother apy are frequently encountered in routine clinical. These agents modulate hemostasis by affecting clotting mechanisms in platelets, clotting factors, or for. Antiplatelet drugs are therefore important for the prevention and treatment of intracardiac and arterial thrombosis and their consequences. Anticoagulants, thrombolytics agents and antiplatelet drugs. Antiplatelet therapy is used for both the management of acute ischemic stroke and for the prevention of stroke. Antiplatelet therapy for stroke prevention slides with. Compared to placebo, stroke risk was reduced by 18% with asa alone p 0.
Ppt antiplatelet therapy for the prevention of stroke in. Chd005 the percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative antiplatelet therapy, or an anticoagulant is being taken 7. Ppt antiplatelet anticoagulant powerpoint presentation. Uncontrolled hypertension htn is the most common cause of spontaneous ich. Give insulin if the patients serum glucose is more than 300. The dual antiplatelet trial dapt is the largest study and was powered for superiority for the primary endpoints of definite or probable st and a composite endpoint of death, mi and stroke. Antiplatelet use was associated with less severe stroke at presentation in those having no history of stroke or tia 4. Antiplatelet therapy is the mainstay for the prevention of primary stroke in patients with risk factors and for the prevention of recurrent stroke after transient ischemic attack tia or ischemic. Dual or mono antiplatelet therapy for the prevention of. Consequently, more attention has been paid to the differences in the clinical efficacy and. Shulga and bornstein antiplatelets in secondary stroke prevention. Take blood samples for blood count, coagulation studies, and blood glucose. Antiplatelet therapy in acs patients with prior stroke. Pdf dual or mono antiplatelet therapy for the prevention of.
Bleeding is the most important side effect of antiplatelet medications. Antiplatelet regimen for patients with breakthrough strokes while. Mode of action of antiplatelet agents ticlopidine ticlid platelet inhibition is irreversible. Ppt antiplatelet and anticoagulant therapy in stroke prevention powerpoint presentation free to download id. Key points for practice a 10 to 21day course of dual antiplatelet therapy reduces stroke recurrence and improves quality of life after mild stroke or highrisk tia. Antiplatelet therapy for secondary prevention of ischemic stroke. Recent advances in neuroimaging, organised stroke care, dedicated neuroicus, medical and surgical management have improved the management of ich. Intracerebral haemorrhage ich is the most devastating and disabling type of stroke. Antiplatelets in stroke ticagrelor potent antiplatelet. Potent antiplatelet medicines prasugrel, ticagrelor 1. Stroke is a feared vascular event among healthy people and those with. A new study representing the largest clinical experience of thrombolysis for stroke in patients receiving antiplatelet therapy suggests.
Ajw200, arc1779, arc15105, alx0081, 82d6 a3 gpvi receptor antagonists. Comparison of antiplatelet regimens in secondary stroke. The article describes the mechanisms of action, pharmacokinetics, and pharmacodynamics of aspirin, dipyridamole, cilostazol, the thienopyridines, and the glycoprotein iibiiia antagonists. Restarting antiplatelet therapy after intracerebral. Factorial analysis demonstrated a highly significant effect for asa and for dipyridamole in reducing the risk of stroke and stroke or death combined. Do not give anticoagulants or antiplatelet treatment for 24 hours after tpa until a followup ct scan at 24 hrs does not show intracranial hemorrhage. Although single antiplatelet therapy is the standard for stroke prevention.
Platelets play a crucial role in the pathogenesis of stroke and antiplatelet agents exist for its. Antiplatelet drugs and anticoagulant medicines are the mainstay of drug treatments for prevention of stroke, whereas fibrinolytics are the principal treatment for most individuals with acute ischemic stroke within the treatment time window. Aspirin reduces risk of mi primary and secondary prevention of mi. Classification of antiplatelet drugs drug group sub groups route name of drugs 1 irreversible cox inhibitor oral aspirin low dose 2 adp receptor blockers p2y thienopyridines oral clopidogrel, prasugrel, ticlopidine, ticagrelor 3 glycoprotein iibiiia inhibitors monoclonal antibody iv abciximab peptide inhibitors iv. Pdf ischemic stroke is defined as a sudden loss of blood to the brain which results in deprivation of oxygen and other nutrients. If validated, b vitamins might have a role in the prevention of ischaemic events in highrisk individuals with an allergy, intolerance, or lack of indication for antiplatelet therapy. Each year, approximately 795,000 people in the united states suffered a stroke of which 185,000 are recurrent attacks. Antiplatelet medications heart and stroke foundation. In 2014, the world heart federation whf, in collaboration with east asian experts, published the first version of a consensus statement on antiplatelet therapy in east asian patients with acute coronary syndrome acs or undergoing percutaneous coronary intervention pci. Antiplatelet drugs an overview sciencedirect topics. Antiplatelet drugs antithrombotics linkedin slideshare. Antiplatelet agents in acute ischemic stroke slideshare. Ticagrelor, elinogrel, cangrelor, bx 667 gpiib iiia antagonist. If you get a cut or nosebleed, gently press on it until the bleeding stops.
691 807 563 31 1470 797 1271 177 883 184 151 1434 1306 632 367 1002 1237 706 1440 960 1418 256 1179 29 1609 1605 772 60 1661 1656 587 859 809 94 649 1103 583 721 691 1494 1440 1408 518